« Return to News | CROs/Service Providers

BioNanomatrix changes name to BioNano Genomics

Tuesday, October 11, 2011 12:48 PM

BioNanomatrix has changed its name to BioNano Genomics.  By adopting the new name, the company is communicating its position as a solution provider for genomics researchers who want to fully understand the biology of the genomes at the core of their research.  The change follows the recent establishment of new corporate headquarters in San Diego, the appointment of new leadership, and additional new investment.

The corporate re-branding reflects the company’s expanding focus on delivering genomic applications for its nanoAnalyzer system, a platform that uses single-molecule imaging to visualize extremely long nucleic acids and reveal genome architecture in its native state. BioNano Genomics makes full genome understanding more accessible to researchers and clinicians who seek simpler ways of examining whole genomes while extending their investigations beyond the realm of variation at the level of only a few nucleotides.

"The change reflects the next evolution of our company as we commercialize a platform that complements and extends the reach of existing genomic technologies by providing the long-range view of genomic variation," said BioNano Genomics president and CEO Dr. R. Erik Holmlin, "BioNano Genomics is intensely focused on helping the research community achieve a more comprehensive understanding of genome biology by developing insight into how the different components of a genome are organized.  This understanding should provide the context that has been missing in our understanding of the link between phenotypic variation and genomic variation."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.